Federal Register of Legislation - Australian Government

Primary content

PB 73 of 2012 Determinations/Health as amended, taking into account amendments up to National Health (Prescriber bag supplies) Amendment Determination 2018 (No. 1) (PB 5 of 2018)
This determination provides for certain pharmaceutical benefits to be obtained, and supplied, by medical practitioners and authorised nurse practitioners directly to patients for treatments. These pharmaceutical benefits are supplied from the prescribers' bag for immediate treatment and are free of charge to patients.
Administered by: Health
Registered 01 Feb 2018
Start Date 01 Feb 2018
End Date 28 Feb 2018
Table of contents.

Commonwealth Coat of Arms of Australia

National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012)

made under sections 93 and 93AB of the

National Health Act 1953

Compilation No. 15

Compilation date:                              1 February 2018

Includes amendments up to:            PB 5 of 2018

Registered:                                         1 February 2018

 

 

 

 

 

 

 

 

 

About this compilation

This compilation

This is a compilation of the National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012) that shows the text of the law as amended and in force on 1 February 2018 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

  

  

  


Contents

1............ Name of Determination................................................................................................. 1

4............ Definitions..................................................................................................................... 1

5............ Pharmaceutical benefits................................................................................................. 1

6............ Maximum quantity........................................................................................................ 2

Schedule—Pharmaceutical benefits that may be supplied by prescriber bag suppliers                                                                                                                                                     3

Endnotes                                                                                                                                                                 6

Endnote 1—About the endnotes                                                                                                        6

Endnote 2—Abbreviation key                                                                                                            7

Endnote 3—Legislation history                                                                                                         8

Endnote 4—Amendment history                                                                                                       9

 


 

 

1  Name of Determination

             (1)  This Determination is the National Health (Prescriber bag supplies) Determination 2012.

             (2)  This Determination may also be cited as PB 73 of 2012.

4  Definitions

                   In this Instrument:

Act means the National Health Act 1953.

authorised midwife has the same meaning as in subsection 84(1) of the Act.

authorised nurse practitioner has the same meaning as in subsection 84(1) of the Act.

prescriber bag supplier in relation to a pharmaceutical benefit means a medical practitioner, authorised midwife or authorised nurse practitioner authorised to supply the pharmaceutical benefit under this Determination.

maximum quantity means maximum quantity or number of units.

pharmaceutical benefit has the same meaning as in subsection 84(1) of the Act.

pharmaceutical benefit has a drug has the same meaning as in subsection 84(1) of the Act.

prescriber bag provisions has the same meaning as in subsection 84(1) of the Act.

5  Pharmaceutical benefits

             (1)  For subsection 93(1) of the Act, a medical practitioner is authorised to supply a pharmaceutical benefit having a drug in a form mentioned in the Schedule if the initials MP are mentioned for the drug and the form in the column headed ‘Prescriber Bag Supplier’ in the Schedule.

             (2)  For subsection 93AB(1) of the Act, an authorised nurse practitioner is authorised to supply a pharmaceutical benefit having a drug in a form mentioned in the Schedule if the initials NP are mentioned for the drug and the form in the column headed ‘Prescriber Bag Supplier’ in the Schedule.

Note:          A pharmaceutical benefit is a brand of a drug in a form with a manner of administration.  The drugs are declared, and the forms, manners of administration and brands are determined, by legislative instrument under subsections 85(2), (3), (5) and (6) of the Act, respectively.

6  Maximum quantity

             (1)  The maximum quantity of pharmaceutical benefits having a drug in a form mentioned in the Schedule which may be obtained by a prescriber bag supplier in any calendar month is the quantity mentioned for the drug and the form in the Schedule under the column headed ‘Maximum Quantity’.

             (2)  The maximum quantity may be obtained for one pharmaceutical benefit only having a drug in a form mentioned in a Group during a calendar month.

             (3)  A quantity, up to the maximum quantity, for a pharmaceutical benefit may be obtained at a particular time only if, at that time, the total quantity of every pharmaceutical benefit having a particular drug in a particular form in the Group, previously obtained in accordance with the prescriber bag provisions of the Act and still in the possession of the supplier, is less than the maximum quantity for a pharmaceutical benefit having that drug in that form.

             (4)  For this section, a Group is each drug in a form mentioned in the Schedule which has the same number mentioned in the column headed ‘Group Number’.


SchedulePharmaceutical benefits that may be supplied by prescriber bag suppliers

  

 

Group Number

Listed Drug

Form

Prescriber Bag Supplier

Maximum Quantity

1

Adrenaline

Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000)

MP, NP

5

2

Atropine

Injection containing atropine sulfate 600 micrograms in 1 mL

MP, NP

10

3

Benztropine

Injection containing benztropine mesylate 2 mg in 2 mL vial

MP, NP

10

4

Benzylpenicillin

Powder for injection 600 mg (as sodium)

MP, NP

5

4

Procaine Penicillin

Injection 1.5 g in disposable syringe

MP, NP

5

5

Benzylpenicillin

Powder for injection 3 g (as sodium)

MP, NP

1

6

Chlorpromazine

Injection containing chlorpromazine hydrochloride 50 mg in 2 mL

MP, NP

10

6

Haloperidol

Injection 5 mg in 1 mL

MP, NP

10

7

Clonazepam

Oral liquid 2.5 mg per mL, 10 mL

MP, NP

1

8

Dexamethasone

Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL

MP, NP

5

8

Hydrocortisone

Injection 100 mg (as sodium succinate) with 2 mL solvent

MP, NP

2

8

Hydrocortisone

Injection 250 mg (as sodium succinate) with 2 mL solvent

MP, NP

1

9

Diazepam

Injection 10 mg in 2 mL

MP, NP

5

10

Diphtheria and tetanus vaccine, adsorbed, diluted for adult use

Injection 0.5 mL in pre‑filled syringe

MP, NP

10

10

Diphtheria and tetanus vaccine, adsorbed, diluted for adult use

Injection 0.5 mL

MP, NP

10

11

Frusemide

Injection 20 mg in 2 mL

MP, NP

5

12

Glucagon

Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe

MP, NP

1

13

Glyceryl Trinitrate

Sublingual spray (pump pack) 400 micrograms per dose, 200 doses

MP, NP

1

14

Hyoscine

Injection containing hyoscine butylbromide 20 mg in 1 mL

MP, NP

5

15

Lignocaine

Injection containing lignocaine hydrochloride 50 mg in 5 mL

MP, NP

5

16

Methoxyflurane

Liquid for inhalation 999.9 mg per g, 3 mL (with inhaler)

MP

1

17

Metoclopramide

Injection containing metoclopramide hydrochloride 10 mg in 2 mL

MP, NP

10

17

Prochlorperazine

Injection containing prochlorperazine mesylate 12.5 mg in 1 mL

MP, NP

10

18

Morphine

Injection containing morphine hydrochloride 10 mg in 1 mL

MP, NP

5

18

Morphine

Injection containing morphine hydrochloride 20 mg in 1 mL

MP, NP

5

18

Morphine

Injection containing morphine sulfate 15 mg in 1 mL

MP, NP

5

18

Morphine

Injection containing morphine sulfate 30 mg in 1 mL

MP, NP

5

19

Naloxone

Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule

MP, NP

10

21

Promethazine

Injection containing promethazine hydrochloride 50 mg in 2 mL

MP, NP

10

22

Salbutamol

Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)

MP, NP

1

22

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

MP, NP

1

22

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

MP, NP

1

23

Salbutamol

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

MP, NP

1

23

Salbutamol

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

MP, NP

1

25

Tramadol

Injection containing tramadol hydrochloride 100 mg in 2 mL

MP, NP

5

26

Midazolam

Injection 5 mg (as hydrochloride) in 1 mL

MP, NP

10

27

Phytomenadione

Injection 10 mg in 1 mL

MP

5

28

Oxytocin

Injection 10 I.U. in 1 mL

MP

5

 

 


Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

 

Endnote 2—Abbreviation key

 

ad = added or inserted

o = order(s)

am = amended

Ord = Ordinance

amdt = amendment

orig = original

c = clause(s)

par = paragraph(s)/subparagraph(s)

C[x] = Compilation No. x

    /sub‑subparagraph(s)

Ch = Chapter(s)

pres = present

def = definition(s)

prev = previous

Dict = Dictionary

(prev…) = previously

disallowed = disallowed by Parliament

Pt = Part(s)

Div = Division(s)

r = regulation(s)/rule(s)

ed = editorial change

reloc = relocated

exp = expires/expired or ceases/ceased to have

renum = renumbered

    effect

rep = repealed

F = Federal Register of Legislation

rs = repealed and substituted

gaz = gazette

s = section(s)/subsection(s)

LA = Legislation Act 2003

Sch = Schedule(s)

LIA = Legislative Instruments Act 2003

Sdiv = Subdivision(s)

(md) = misdescribed amendment can be given

SLI = Select Legislative Instrument

    effect

SR = Statutory Rules

(md not incorp) = misdescribed amendment

Sub‑Ch = Sub‑Chapter(s)

    cannot be given effect

SubPt = Subpart(s)

mod = modified/modification

underlining = whole or part not

No. = Number(s)

    commenced or to be commenced

 

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

PB 73 of 2012

27 Sept 2012 (F2012L01955)

1 Oct 2012 (s 2)

 

PB 100 of 2012

29 Nov 2012 (F2012L02289)

1 Dec 2012 (s 2)

PB 23 of 2013

24 Apr 2013 (F2013L00681)

1 May 2013 (s 2)

PB 90 of 2013

20 Dec 2013 (F2013L02168)

1 Jan 2014 (s 2)

PB 91 of 2014

28 Nov 2014 (F2014L01617)

1 Dec 2014 (s 2)

 

PB 107 of 2014

22 Dec 2014 (F2014L01789)

1 Jan 2015 (s 2)

PB 7 of 2015

15 Jan 2015 (F2015L00042)

1 Feb 2015 (s 2)

PB 14 of 2015

25 Feb 2015 (F2015L00209)

1 Mar 2015 (s 2)

PB 29 of 2015

26 Mar 2015 (F2015F00339)

1 Apr 2015 (s 2)

PB 42 of 2015

24 Apr 2015 (F2015L00588)

1 May 2015 (s 2)

PB 115 of 2015

1 Dec 2015 (F2015L01903)

1 Dec 2015 (s 2)

PB 43 of 2016

31 May 2016 (F2016L00880)

1 June 2016 (s 2)

PB 64 of 2016

19 July 2016 (F2016L01195)

1 Aug 2016 (s 2)

PB 17 of 2017

30 Mar 2017 (F2017L00356)

1 Apr 2017 (s 2)

PB 37 of 2017

31 May 2017 (F2017L00621)

1 June 2017 (s 2)

PB 5 of 2018

24 Jan 2018 (F2018L00056)

1 Feb 2018 (s 2)

Endnote 4—Amendment history

 

Provision affected

How affected

s 2.............................................

rep LIA s 48D

s 3.............................................

rep LIA s 48C

Schedule

 

Schedule................................... .................................................

am PB 100 of 2012; PB 23 and 90 of 2013; PB 91 and 107 of 2014; PB 7, 14, 29, 42 and 115 of 2015; PB 43 of 2016; PB 64 of 2016; PB 17 of 2017; PB 37 of 2017; PB 5 of 2018